Yi-Tsung Lu MD (He/Him)

PubMed

• 19 citations
  Cell-free DNA Methylation as a Predictive Biomarker of Response to Neoadjuvant Chemotherapy for Patients with Muscle-invasive Bladder Cancer in SWOG S1314.
  Yi-Tsung Lu, Melissa Plets, Gareth Morrison, Alexander T Cunha, Steven Y Cen
  European Urology Oncology. 2023-10-01
• 11 citations
  Bladder cancer cells shift rapidly and spontaneously to cisplatin-resistant oxidative phosphorylation that is trackable in real time.
  Tong Xu, Jason A Junge, Alireza Delfarah, Yi-Tsung Lu, Cosimo Arnesano
  Scientific Reports. 2022-04-01
• 10 citations
  FOXC1 Binds Enhancers and Promotes Cisplatin Resistance in Bladder Cancer.
  Yi-Tsung Lu, Tong Xu, Maheen Iqbal, Tien-Chan Hsieh, Zhifei Luo
  Cancers. 2022-03-28

Abstracts/Posters

• Single-CTC whole genome sequencing in prostate cancer.
  Lu YT, Jiang R, Tseng HR, and Posadas EM, AACR-Prostate Cancer Foundation Conference on Advances in Prostate Cancer Research, San Diego, CA, 1/1/2014
• Single-CTC whole genome sequencing in prostate cancer.
  Lu YT, and Posadas EM, 5th Cedars-Sinai Medical Center Research Day, Los Angeles, CA, 1/1/2014
• Circulating Tumor Cells as a Surrogate Tissue Source for Whole Genome Sequencing in Prostate Cancer.
  Lu YT, Li B, Jiang R, Tseng HR, and Posadas EM, 10th World Congress on Urologic Research, Nashville, TN, 1/1/2013
• Circulating Tumor Cells as a Surrogate Tissue Source for Whole Genome Sequencing in Prostate Cancer.
  Lu YT, Hou S, Wu K, Li B, Li F, Lin M, OuYang W, Tseng HR, and Posadas EM, 2013 UCLA-USC-Caltech Nanotechnology & Nanomedicine Symposium, Los Angeles, CA, 1/1/2013
• Join now to see all

Lectures

• Epigenomic profiling of plasma cell-free DNA (cfDNA) to predict bladder cancer recurrence after radical cystectomy. 
  2019 ASCO Annual Meeting - 6/1/2019
• "Liquid biopsies and molecular profiling of cell-free DNA." 
  Los Angeles, CA - 1/8/2018
• "Single-cell whole genome sequencing of CTCs in prostate cancer." 
  Cedars-Sinai Medical Center, Los Angeles, CA - 1/29/2014
• "Single-cell whole-genome sequencing verifies the surrogacy of circulating tumor cells for prostate cancer." 
  San Diego, CA - 1/6/2014
• "Single circulating tumor cell for whole genome sequencing." 
  Los Angeles, CA - 1/30/2013
• Join now to see all